Lifeway Foods (LWAY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 May, 2026Executive summary
The 2026 Annual Meeting will be held virtually on June 17, 2026, with shareholders voting on director elections, auditor ratification, and executive compensation.
Shareholders of record as of April 20, 2026, are eligible to vote, with 15,281,888 shares outstanding, each entitled to one vote per share.
The Board recommends voting FOR all proposals, including the election of seven directors, ratification of Grant Thornton LLP as auditor, and approval of executive compensation.
Voting matters and shareholder proposals
Proposals include electing seven directors, ratifying Grant Thornton LLP as independent auditor for 2026, and a non-binding advisory vote on executive compensation.
Shareholders may submit proposals for the 2027 meeting by December 31, 2026, and director nominations between February 18 and March 20, 2027.
The Board entered a Cooperation Agreement with Danone, influencing board nominations and compensation practices.
Board of directors and corporate governance
The Board will be reduced to seven members, with new independent directors nominated per the Cooperation Agreement with Danone.
Board leadership transitioned to an independent Chairperson, Dorri McWhorter, in November 2025.
All committees are composed solely of independent directors, and annual board and committee evaluations are conducted.
The ACG Committee combines audit and nominating functions, and the Compensation Committee oversees executive pay.
Director and executive stock ownership policies require holding stock valued at 200% of annual base salary or retainer.
Latest events from Lifeway Foods
- Votes will be cast on board elections, auditor ratification, and executive pay at the 2026 meeting.LWAY
Proxy filing30 Apr 2026 - Record sales and profit growth, margin expansion, and innovation drive strong 2026 outlook.LWAY
Q4 202517 Mar 2026 - Q2 net sales rose 25.3% to $49.2M, net income hit $3.8M, and all debt was repaid.LWAY
Q2 20241 Feb 2026 - Q3 2024 sales up 12.7%, net income $3M, global expansion, and Danone bid rejected.LWAY
Q3 202414 Jan 2026 - ISS backs the full board slate for the 2025 meeting, urging shareholders to vote accordingly.LWAY
Proxy Filing19 Dec 2025 - Up to 3.45 million shares are being resold by a major shareholder as part of a governance agreement.LWAY
Registration Filing16 Dec 2025 - Board refreshes with independent directors, urges rejection of dissident nominees amid strong results.LWAY
Proxy Filing11 Dec 2025 - Proxy contest targets board overhaul, new oversight committee, and governance reforms.LWAY
Proxy Filing5 Dec 2025 - Board urges rejection of dissident nominees amid strong performance and governance refresh.LWAY
Proxy Filing2 Dec 2025